Viridian Therapeutics, Inc.\DE (VRDN) Preferred Dividend Payments (2016 - 2017)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Preferred Dividend Payments of $5000.0 for Q1 2017, up 141.67% year-over-year from $2069.0 in Q1 2016, and down 58.33% quarter-over-quarter from $12000.0 in Q4 2016.
Viridian Therapeutics, Inc.\DE (VRDN) Preferred Dividend Payments (2016 - 2017) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $5000.0 for Q1 2017.
- In Q1 2017, Preferred Dividend Payments rose 141.67% year-over-year to $5000.0; the TTM figure through Dec 2017 stood at $5000.0 (down 80.0% YoY), while the FY2017 annual figure was $5000.0, down 89.8% from the prior year.
- Preferred Dividend Payments for Q1 2017 stood at $5000.0, down from $12000.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $13000.0 in Q3 2016, with the low at -$12000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 2.50 Bn | 2.50 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 5,000.00 |
| Dec 31, 2016 | 12,000.00 |
| Sep 30, 2016 | 13,000.00 |
| Jun 30, 2016 | 12,000.00 |
| Mar 31, 2016 | -12,000.00 |